L&G Healthcare Technology & Innovation UCITS ETF

PhysicalIndex replication
AccumulatingDistribution policy
0.49 %TER
£269.77M Fund size
61Number of positions
0.45 % TD
21.82 %Top 10 share
USDCurrency
5SRI

Current price

£13.46
19 Nov 2026
1D
1W
1M
3M
6M
1Y
3Y
Max

Description

The L&G Healthcare Breakthrough UCITS ETF (the "Fund") is a passively managed exchange traded fund ("ETF") that aims to track the performance of the ROBO Global® Healthcare Technology and Innovation Index TR (the "Index"), subject to the deduction of the ongoing charges and other costs associated with operating the Fund.  The Fund has a sustainable investment objective as it invests in companies which (i) contribute to social objectives, (ii) do not significantly harm any environmental or social objectives, and (iii) follow good governance practices. Further information can be found in the Fund Supplement.  Dealing. Shares in this Share Class (the “Shares”) are denominated in USD and can be bought and sold on stock exchanges by ordinary investors using an intermediary (e.g. a stockbroker). In normal circumstances, only Authorised Participants may buy and sell Shares directly with the Company. Authorised Participants may redeem their Shares on demand in accordance with the “Dealing Timetable” published on http://www.lgim.com.  Index. The Index is comprised of companies which are publically traded on various stock exchanges around the world that generate a proportion of their revenues from the healthcare technology industry. The industry is deemed to be comprised of the following nine sub-sectors: diagnostic, lab process automation, genomics, regenerative medicine, precision medicine, telehealth, data analytics, robotics and medical instruments. A company is only eligible for inclusion in the Index if it is of a sufficient size (determined by reference to the total market value of its shares) and it is sufficiently “liquid” (a measure of how actively its shares are traded on a daily basis). Within the Index, companies involved in the healthcare technology industry are assigned a score based on (a) a company's revenue from healthcare technology, (b) levels of investment in healthcare technology and (c) market positioning in the healthcare technology industry (the “Score”). Constituents are weighted according to their Score. Each constituent’s weight is calculated by dividing its Score by the sum of all available Scores in the eligible universe.  Replication. The Fund will primarily invest in the companies contained in the Index in similar proportions to their weightings in the Index. The Fund may also invest in (1) “technology” companies that are not constituents of the Index that have similar risk and performance characteristics to the companies contained in the Index and (2) financial derivative instruments (“FDIs”) (i.e. investments the prices of which are based on the companies contained in the Index and/or such other “technology” companies).  Dividend Policy. This Share Class does not intend to pay dividends. Any income which may result from the Fund’s investments will be re-invested into the Fund.

Return

Here you can see the performance (incl. distributions) of the L&G Healthcare Technology & Innovation UCITS ETF.

Period Perfor­mance
1 Week-3.92 %
1 Month-0.62 %
3 Months+1.19 %
6 Months+29.42 %
1 Year+27.11 %
3 Years+65.34 %(18.25 % p.a.)
5 Years-1.96 %(-0.39 % p.a.)
10 Years—
Since inception +75.17 %(7.87 % p.a.)
Year Perfor­mance
YTD+22.22 %
2025+9.56 %
2024+9.95 %
2023-6.13 %
2022-28.98 %
2021+7.75 %
As of: 19 Nov 2026. Performance displayed in GBP

Master data

Key master data for the L&G Healthcare Technology & Innovation UCITS ETF

Total expense ratio (TER) 0.49 %
Index replication Physical
Replication method Full
Distribution policy Accumulating
Fund size £269.77M
Fund launch 26 Jun 2019
Fund currency USD
Currency hedging No 
Fund domicileIrland
Risk indicator (SRI)
5 · medium-high risk class

Risk metrics

Key risk and analysis metrics for the L&G Healthcare Technology & Innovation UCITS ETF

Volatility
17.00 % 1 Year
18.58 % 3 Years
20.27 % 5 Years
max. Drawdown
-10.46 % 1 Year
-13.06 % 3 Years
-51.49 % 5 Years
Sharpe Ratio
1.70 1 Year
1.14 3 Years
-0.07 5 Years
XLM
46.95

Information about the ROBO Gbl Healthcare Tech & Innov TR USD Index

Index name ROBO Gbl Healthcare Tech & Innov TR USD (1)
Included securities 64
Stock positions 61
Bond positions 0
Cash and other positions 3

More ETFs tracking the ROBO Gbl Healthcare Tech & Innov TR USD Index

Here you can find alternative index funds for the ROBO Gbl Healthcare Tech & Innov TR USD.

Frequently asked questions

Here you will find all answers to your questions about the L&G Healthcare Technology & Innovation UCITS ETF

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.